Modulus Therapeutics - Cell Therapy Assets - Ownership and Business Overview

Life ScienceCompany

Modulus Therapeutics - Cell Therapy Assets Ownership

Who owns Modulus Therapeutics - Cell Therapy Assets?

Modulus Therapeutics - Cell Therapy Assets is owned by Ginkgo Bioworks. It was acquired on April 2, 2024.

Modulus Therapeutics - Cell Therapy Assets Business Overview

Where is Modulus Therapeutics - Cell Therapy Assets headquartered?

Modulus Therapeutics - Cell Therapy Assets is headquartered in Seattle, Washington.

What sector is Modulus Therapeutics - Cell Therapy Assets in?

Modulus Therapeutics - Cell Therapy Assets is a life science company.

Life Science M&A Summary in 2024

Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2024. The largest life science acquisition in 2024 was Catalent - which was acquired by Novo Holdings A/S for $16.5B.

Join Mergr to view all 195 acquisitions of life science companies in 2024, including 17 acquisitions by private equity firms, and 178 by strategics.

Modulus Therapeutics - Cell Therapy Assets

Modulus Therapeutics - Cell Therapy Assets

Seattle, Washington
United States,

Modulus Therapeutics' Cell Therapy Assets provides chimeric antigen receptor (CAR) and switch receptor libraries.


Company Summary

SECTOR

Life Science

 Subscribe to unlock this and 208,055
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More
1 Week Free Trial Learn More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 201K M&A Transactions
  • 203K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.

Related Lists for Modulus Therapeutics - Cell Therapy Assets

Washington Companies , Life Science Companies , United States Companies , Washington Life Science Companies , Washington Life Science with Acquisitions , Washington Life Science with Divestitures

Related Lists for Washington Companies

Largest Washington Companies , Acquisitive Washington Companies , Recently Acquired Washington Companies , Recently Sold Washington Companies , Private Washington Companies , Public Washington Companies , Acquired Washington Companies , PE Backed Washington Companies

Related Lists for Life Science Companies

Largest Life Science Companies , Acquisitive Life Science Companies , Recently Acquired Life Science Companies , Recently Sold Life Science Companies , Private Life Science Companies , Public Life Science Companies , Acquired Life Science Companies , PE Backed Life Science Companies

Related Lists for United States Companies

Largest United States Companies , Acquisitive United States Companies , Recently Acquired United States Companies , Recently Sold United States Companies , Private United States Companies , Public United States Companies , Acquired United States Companies , PE Backed United States Companies
Mergr

Product

Company

Legal